We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Privacy Policy.
Hartford, CT — Two-thirds of employers in the United States are or will be affected by the opioid epidemic, according to the results of a recent survey.
Washington — Nearly 40 percent of pregnant nurses don’t wear protective gowns when administering powerful cancer drugs, putting their own health and that of their unborn babies at risk, results of a recent study from NIOSH suggest.
Secaucus, NJ — The rate of positive drug tests rose by double digits in five of 16 major U.S. workforce industry sectors from 2015 to 2017, according to a recent analysis by lab services provider Quest Diagnostics.
Richmond, British Columbia — In response to the Oct. 17 legalization of recreational marijuana in Canada, WorkSafeBC has launched an awareness campaign in an effort to educate employers and workers about impairment on the job.
In a memo sent Oct. 11 to regional administrators and state designees, the agency outlines examples of acceptable drug testing, and states that incentive programs that withhold prizes because of an injury are compliant “as long as the employer has implemented precautions to ensure that employees feel free to report an injury or illness.”
Washington — The Department of Labor Office of Workers’ Compensation Programs has unveiled a four-point Opioid Action Plan intended to help combat opioid misuse among injured federal employees.
Atlanta — Construction workers have the highest proportional mortality ratio for heroin- and methadone-related overdose deaths, a Centers for Disease Control and Prevention analysis of 26 occupations shows.
Washington — The Office of National Drug Control Policy, in partnership with the U.S. Department of Agriculture, has published a guide intended to help rural communities address opioid misuse and other substance abuse by providing a centralized list of federal programs and resources.
Washington — The Senate on Oct. 3 passed an extensive package of bipartisan opioid legislation with provisions that include boosting efforts to improve the coordination of emergency department overdose care and advancing hair testing as an accepted drug-testing method for transportation industry employees.